News Posts List
Charity Navigator: Kidney Cancer Association Awarded Four Stars
10/22/2010
Charity Navigator, the nation's premiere charity evaluator, has awarded the Kidney Cancer Association its coveted 4-star rating for the third consecutive year. Less than 15% of rated charities achieve this distinction.
Canada's socialist public health care at crossroads
10/22/2010
Linda Irving is concerned about abdominal pains she's had for a few months, and skittish about the four-month wait her sister-in-law endured before recently undergoing kidney cancer surgery.
Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma
10/22/2010
On the basis of potential additive or synergistic immunostimulatory antitumor effects, in this phase 1 study, the authors evaluated the combination of sunitinib and tremelimumab (CP675206; an antibody against cytotoxic Tlymphocyteassociated antigen 4 [CTLA4]) in patients with metastatic renal cell carcinoma (mRCC) was evaluated.
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
10/22/2010
The enhancer of zeste homolog 2 (EZH2) gene exerts oncogenelike activities and its (over)expression has been linked to several human malignancies. Here, authors studied a possible association between EZH2 expression and prognosis in patients with renal cell carcinoma (RCC).
Report: Drug Companies Pay 17,000 U.S. Doctors
10/20/2010
The payments are not illegal and usually not even considered improper.
Link between diabetes and kidney cancer
10/15/2010
A positive association between diabetes and kidney cancer has been reported in several investigations.
Unique Cancer Survivors' Summit
10/13/2010
More than 120 cancer survivors and caregivers, cancer-treating physicians, and patient advocates gathered in San Diego to share their Proleukin® (aldesleukin for injection) treatment experiences.
High-risk insurance pool accepts patients with pre-existing conditions
10/11/2010
Consumers previously rejected by insurers or forced to wait six months for coverage because they have costly medical problems are starting to get benefits from a new statewide program for uninsured people.
A Tunable, Cloaked, System To Kill Tumors From Inside
10/04/2010
Researchers led by University of Massachusetts Amherst chemist Vincent Rotello have demonstrated that they can deliver a dormant toxin into a specific site such as a tumor for anti-cancer therapy, then chemically trigger the toxin to de-cloak and attack from within.
Stereotactic Body Radiation Therapy (SBRT) for Genitourinary Malignancies
10/04/2010
There are now emerging data that show the safety and efficacy of this treatment modality in genitourinary malignancies especially in prostate cancer and renal cell carcinoma.